04/23/2024
3:20 PM | ARCA biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2024
4:29 PM | Allostery Investments LP (Filed by)
ARCA biopharma (Subject)
| Form SC 13G | |
04/11/2024
8:51 AM | ARCA biopharma (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G | |
04/09/2024
7:57 PM | ARCA biopharma (Subject)
Avidity Partners Management LP (Filed by)
| Form SC 13G | |
04/05/2024
6:38 PM | ARCA biopharma (Subject)
Western Standard LLC (Filed by)
| Form SC 13G/A | |
04/03/2024
6:31 AM | ARCA biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2024
6:33 AM | ARCA biopharma (Subject)
| Form 425 | |
02/07/2024
12:08 PM | ARCA biopharma (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G/A | |
02/01/2024
3:39 PM | ARCA biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
5:39 PM | ARCA biopharma (Issuer)
Ma-Weaver Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:25 PM | ARCA biopharma (Issuer)
Woosley Raymond L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:25 PM | ARCA biopharma (Issuer)
Grais Linda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:25 PM | ARCA biopharma (Issuer)
CONWAY ROBERT E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:25 PM | ARCA biopharma (Issuer)
Flynn James P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:25 PM | ARCA biopharma (Issuer)
MITCHELL DANIEL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:25 PM | ARCA biopharma (Issuer)
Hove Anders D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
3:25 PM | ARCA biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2023
3:36 PM | ARCA biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2023
3:15 PM | ARCA biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/18/2023
3:35 PM | ARCA biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/21/2023
3:35 PM | ARCA biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/21/2023
3:16 PM | ARCA biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2023
3:35 PM | ARCA biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2023
3:16 PM | ARCA biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
